Skip to content
Faculty
Agenda
Poster Competition
Accommodations
Accreditation
About
Menu
Faculty
Agenda
Poster Competition
Accommodations
Accreditation
About
Registration
AGenda
Welcome Day
Thursday
, August 1, 2024
New-York Historical Society, Lobby
6:00 PM - 9:00 PM
World GU Poster Presentation & Welcome Reception
Day One
Friday
, August 2, 2024
Breakfast Symposium (Non-CE)
New-York Historical Society
7:30 AM - 8:20 AM
Prostate Cancer:
Applying the Goldilocks Principle in Advanced Prostate Cancer: Matching Disease Aggressiveness and Treatment Intensity to Optimize Outcomes
Chair: Alicia Morgans, MD, MPH
New-York Historical Society, General Session
8:40 AM - 10:00 AM
Oligometastatic Prostate Cancer: MDT approach - Surgeons Perspective
Oligometastatic and Oligoprogressive Disease - Radiation Oncology Perspective
Debate: Doublet vs Triplet Therapy in mHSPC
Updates in High-Risk Hormone Sensitive Biochemical Recurrence
Racial Disparities in Prostate Cancer Care
Community Case
Q&A
Networking Break
New-York Historical Society, Lobby
10:10 AM - 10:40 AM
Prostate Cancer:
Hot off the FDA presses: Thinking through therapeutic advances and recent approvals in mCRPC
Chair: Alicia Morgans, MD, MPH
New-York Historical Society, General Session
10:40 AM - 12:00 PM
Targeting the Immune Response
Next Generation Radioligand Therapies
Novel Approaches To Treatment Of mCRPC
Updates In Current Approaches To Radioligand Therapy
Debate: PARPinhibitor Combinations - Pro vs Con
Q&A
Lunch Symposium (Non-CE)
New-York Historical Society
12:10 PM - 1:10 PM
Special Session
New-York Historical Society
1:30 PM - 1:50 PM
Leading the Way in Community oncology: an Interview with Dr. Jeff Vacirca
Renal Cell Carcinoma:
In the Right Space at the Right Time: Idealized Management of Kidney Cancer
Chair: Dan George, MD
New-York Historical Society, General Session
1:50 PM - 3:00 PM
Community Case
Patient Selection for Adjuvant Treatment and Trials
Molecular Markers of Microscopic Disease
Debate: Upfront vs Delayed Nephrectomy For Low Volume Metastatic RCC
Consolidative Focal Therapy
Q&A
Networking Break
New-York Historical Society, Lobby
3:10 PM - 3:40 PM
Renal Cell Carcinoma:
Remixing the Management of Metastatic Renal Cell Carcinoma
Chair: Dan George, MD
New-York Historical Society, General Session
3:40 PM - 5:00 PM
How do we Risk Stratify Beyond IMDC?
Management of Favorable Risk RCC: Goals and Tx Endpoints
Debate: IO/IO vs IO/TKI in the Treatment of Intermediate Risk RCC
Sequential vs Concomitant Therapies
Novel Agents - Where Do We Introduce?
Q&A
Keynote Presentation
New-York Historical Society
5:00 PM - 5:45 PM
Day Two
Saturday
, August 3, 2024
Breakfast Symposium (Non-CE)
New-York Historical Society
7:30 AM - 8:20 AM
Featured Session: THE UROMIGOS
-
The Intersection of Clinical Trials & Community Practice
New-York Historical Society, General Session
8:30 AM - 10:30 AM
Networking Break
New-York Historical Society, Lobby
10:30 AM - 11:00 AM
Tools For Today's Oncologist
Chairs: Jahan Aghalar, MD & Talha Shaikh, MD, MBA
New-York Historical Society, General Session
11:00 AM - 12:00 PM
NGS, Testing & Biomarkers in Genitourinary Cancers
Social Media for the Oncologist
HealthCare Policy
New York Cancer & Blood Specialists/Memorial Sloan Kettering Cancer Center Collaboration Highlights & Best Practices
Q&A
Lunch Symposium (Non-CE)
New-York Historical Society
12:10 PM - 1:10 PM
Bladder Cancer:
Multidisciplinary Management of Localized Bladder Cancer
Chair: Shilpa Gupta, MD
New-York Historical Society, General Session
1:30 PM - 2:50 PM
Debate: Chemo-RT vs Radical Cystectomy in the Treatment of MIBC
IBCG Consensus Update on Bladder Preservation in MIBC
Bladder Preservation After Neoadjuvant Treatment in MIBC
Future of Perioperative Therapy in Bladder Cancer
NMIBC - Defining Trial Endpoints
NMIBC- Novel Bladder Sparing Treatments
Community Case
Q&A
Networking Break
New-York Historical Society, Lobby
3:00 PM - 3:30 PM
Bladder Cancer
- Personalized Medicine and Novel Agents in Bladder Cancer
Chair: Shilpa Gupta, MD
New-York Historical Society, General Session
3:30 PM - 4:50 PM
Community Case
Choosing First-Line Systemic Treatment in Bladder Cancer
Sequencing of Therapies in the Evolving Paradigm
Role of Biomarkers in Bladder Cancer
Optimizing Dosing of ADCs and Management of Adverse Events
Trial Development in Rare Variant Histologies
Future Of ADCs And Targeted Therapies in mUC
Q&A
Close
Farewell Reception
New-York Historical Society, Lobby
5:00 PM - 7:00 PM
*Agenda is subject to change.
Experience New York
Come for the education.
Stay for the fun.